Related references
Note: Only part of the references are listed.Molecular Mechanisms and Current Treatment Options for Cancer Cachexia
Syed Sayeed Ahmad et al.
CANCERS (2022)
Standardized phytopreparations and cucurbitacin IIb from Ibervillea sonorae (S. Watson) greene induce apoptosis in cervical cancer cells by Nrf2 inhibition
Max Vidal-Gutierrez et al.
JOURNAL OF ETHNOPHARMACOLOGY (2022)
Cucurbitacin IIb improved active chromatin-induced systemic lupus erythematosus via balancing the percentage of Th17 and Treg cells
Dongke Wu et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2021)
Cucurbitacin IIb induces apoptosis and cell cycle arrest through regulating EGFR/MAPK pathway
Yuan Liang et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2021)
Prolonged caloric restriction ameliorates age-related atrophy in slow and fast muscle fibers of rat soleus muscle
Yuhei Mizunoe et al.
EXPERIMENTAL GERONTOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Phenotypic features of cancer cachexia-related loss of skeletal muscle mass and function: lessons from human and animal studies
Agnes Martin et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2021)
MRTF-A regulates myoblast commitment to differentiation by targeting PAX7 during muscle regeneration
Ruhui Song et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
Cancer-Mediated Muscle Cachexia: Etiology and Clinical Management
Thomas Siff et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2021)
Control of Skeletal Muscle Atrophy Associated to Cancer or Corticosteroids by Ceramide Kinase
Federica Pierucci et al.
CANCERS (2021)
Myosin heavy chain-embryonic regulates skeletal muscle differentiation during mammalian development
Megha Agarwal et al.
DEVELOPMENT (2020)
Management of Cancer Cachexia: Attempting to Develop New Pharmacological Agents for New Effective Therapeutic Options
Gioacchino P. Marceca et al.
FRONTIERS IN ONCOLOGY (2020)
Management of Cancer Cachexia: ASCO Guideline
Eric J. Roeland et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Cucurbitacin IIb, a steroidal triterpene from Ibervillea sonorae induces antiproliferative and apoptotic effects on cervical and lung cancer cells
Heriberto Torres-Moreno et al.
STEROIDS (2020)
Investigational drugs for the treatment of cancer cachexia: a focus on phase I and phase II clinical trials
Alessio Molfino et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2019)
Mixing it up: the biological significance of hybrid skeletal muscle fibers
Scott Medler
JOURNAL OF EXPERIMENTAL BIOLOGY (2019)
Cancer cachexia and myopenia - Update on management strategies and the direction of future research for optimizing body composition in cancer - A narrative review
Edward T. Pring et al.
CANCER TREATMENT REVIEWS (2018)
Skeletal muscle regeneration in cancer cachexia
Maurizio Bossola et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2016)
Molecular Pathways: Cachexia Signaling-A Targeted Approach to Cancer Treatment
Yuji Miyamoto et al.
CLINICAL CANCER RESEARCH (2016)
Cancer-associated malnutrition, cachexia and sarcopenia: the skeleton in the hospital closet 40 years later
Aoife M. Ryan et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2016)
F-BOX proteins in cancer cachexia and muscle wasting: Emerging regulators and therapeutic opportunities
Ammar Sukari et al.
SEMINARS IN CANCER BIOLOGY (2016)
Computed tomography-defined muscle and fat wasting are associated with cancer clinical outcomes
Seyyed Mohammad Reza Kazemi-Bajestani et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2016)
STAT3 in the systemic inflammation of cancer cachexia
Teresa A. Zimmers et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2016)
Inhibition of Stat3 Activation Suppresses Caspase-3 and the Ubiquitin-Proteasome System, Leading to Preservation of Muscle Mass in Cancer Cachexia
Kleiton Augusto Santos Silva et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: An in vitro and in vivo study
Lei Yuan et al.
ONCOLOGY REPORTS (2015)
Cancer cachexia, mechanism and treatment
Tomoyoshi Aoyagi et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2015)
Skeletal Muscle Depletion and Markers for Cancer Cachexia Are Strong Prognostic Factors in Epithelial Ovarian Cancer
Stefanie Aust et al.
PLOS ONE (2015)
Cucurbitacin IIb Exhibits Anti-Inflammatory Activity through Modulating Multiple Cellular Behaviors of Mouse Lymphocytes
Yao Wang et al.
PLOS ONE (2014)
Role of interleukin-6 in cachexia: therapeutic implications
Aditi A. Narsale et al.
CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE (2014)
Stat3 Activation Links a C/EBPδ to Myostatin Pathway to Stimulate Loss of Muscle Mass
Liping Zhang et al.
CELL METABOLISM (2013)
Mechanisms for fiber-type specificity of skeletal muscle atrophy
Yichen Wang et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2013)
The decline in skeletal muscle mass with aging is mainly attributed to a reduction in type II muscle fiber size
Rachel Nilwik et al.
EXPERIMENTAL GERONTOLOGY (2013)
gp130: a promising drug target for cancer therapy
Shili Xu et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2013)
Distinct transcriptional regulatory modules underlie STAT3's cell type-independent and cell type-specific functions
Andrew Paul Hutchins et al.
NUCLEIC ACIDS RESEARCH (2013)
Apoptosis in Skeletal Myocytes: A Potential Target for Interventions against Sarcopenia and Physical Frailty - A Mini-Review
Emanuele Marzetti et al.
GERONTOLOGY (2012)
Definition and classification of cancer cachexia: an international consensus
Kenneth Fearon et al.
LANCET ONCOLOGY (2011)
Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia
Margaret E. Benny Klimek et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
Thick and thin filament gene mutations in striated muscle diseases
Homa Tajsharghi
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2008)
Satellite cell content is specifically reduced in type II skeletal muscle fibers in the elderly
Lex B. Verdijk et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Cucurbitacins and cucurbitane glycosides: structures and biological activities
JC Chen et al.
NATURAL PRODUCT REPORTS (2005)
Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy
M Sandri et al.
CELL (2004)
Share Paper
